Outside U.K., the blush is still on the rose

Eurostocks

OXFORD - Europe continues to send mixed signals. While the U.K. biotech sector is in the tank - the BioCentury London Index has declined some 25 percent over the first half - the market performance of companies on the continent has been fairly robust...